Microfluidic DNA-based potassium nanosensors for improved dialysis treatment

Patients with end-stage renal disease (ESRD) have failed kidney function, and often must be treated with hemodialysis to extend the patient’s life by artificially removing excess fluid and toxins from the bloo…
Source: Biomedical Engineering Online

Advertisements

Leave a Reply